409 related articles for article (PubMed ID: 36423144)
1. ACE2-Independent Alternative Receptors for SARS-CoV-2.
Lim S; Zhang M; Chang TL
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423144
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 cell entry beyond the ACE2 receptor.
Alipoor SD; Mirsaeidi M
Mol Biol Rep; 2022 Nov; 49(11):10715-10727. PubMed ID: 35754059
[TBL] [Abstract][Full Text] [Related]
3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry.
Zhu S; Liu Y; Zhou Z; Zhang Z; Xiao X; Liu Z; Chen A; Dong X; Tian F; Chen S; Xu Y; Wang C; Li Q; Niu X; Pan Q; Du S; Xiao J; Wang J; Wei W
Sci China Life Sci; 2022 Apr; 65(4):701-717. PubMed ID: 34431042
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
11. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
Achom A; Das R; Pakray P
Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
13. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2.
Gu Y; Cao J; Zhang X; Gao H; Wang Y; Wang J; He J; Jiang X; Zhang J; Shen G; Yang J; Zheng X; Hu G; Zhu Y; Du S; Zhu Y; Zhang R; Xu J; Lan F; Qu D; Xu G; Zhao Y; Gao D; Xie Y; Luo M; Lu Z
Cell Res; 2022 Jan; 32(1):24-37. PubMed ID: 34837059
[TBL] [Abstract][Full Text] [Related]
14. Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
Barthe M; Hertereau L; Lamghari N; Osman-Ponchet H; Braud VM
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047226
[TBL] [Abstract][Full Text] [Related]
15. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
17. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
Baggen J; Jacquemyn M; Persoons L; Vanstreels E; Pye VE; Wrobel AG; Calvaresi V; Martin SR; Roustan C; Cronin NB; Reading E; Thibaut HJ; Vercruysse T; Maes P; De Smet F; Yee A; Nivitchanyong T; Roell M; Franco-Hernandez N; Rhinn H; Mamchak AA; Ah Young-Chapon M; Brown E; Cherepanov P; Daelemans D
Cell; 2023 Aug; 186(16):3427-3442.e22. PubMed ID: 37421949
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
20. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
